260 related articles for article (PubMed ID: 11737066)
1. Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.
Martin E; Triccas JA; Kamath AT; Winter N; Britton WJ
Clin Exp Immunol; 2001 Dec; 126(3):482-7. PubMed ID: 11737066
[TBL] [Abstract][Full Text] [Related]
2. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.
Martin E; Kamath AT; Briscoe H; Britton WJ
Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627
[TBL] [Abstract][Full Text] [Related]
3. DNA encoding a single mycobacterial antigen protects against leprosy infection.
Martin E; Roche PW; Triccas JA; Britton WJ
Vaccine; 2001 Jan; 19(11-12):1391-6. PubMed ID: 11163661
[TBL] [Abstract][Full Text] [Related]
4. Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.
Martin E; Kamath AT; Triccas JA; Britton WJ
Infect Immun; 2000 Jun; 68(6):3090-6. PubMed ID: 10816448
[TBL] [Abstract][Full Text] [Related]
5. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
6. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
[TBL] [Abstract][Full Text] [Related]
7. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis.
Young SL; Slobbe LJ; Peacey M; Gilbert SC; Buddle BM; de Lisle GW; Buchan GS
Immunol Cell Biol; 2010 Aug; 88(6):651-7. PubMed ID: 20231853
[TBL] [Abstract][Full Text] [Related]
11. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
[TBL] [Abstract][Full Text] [Related]
12. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
[TBL] [Abstract][Full Text] [Related]
13. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
[TBL] [Abstract][Full Text] [Related]
14. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.
Ferraz JC; Stavropoulos E; Yang M; Coade S; Espitia C; Lowrie DB; Colston MJ; Tascon RE
Infect Immun; 2004 Dec; 72(12):6945-50. PubMed ID: 15557616
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA.
Hogarth PJ; Logan KE; Ferraz JC; Hewinson RG; Chambers MA
Vaccine; 2006 Jan; 24(1):95-101. PubMed ID: 16314009
[TBL] [Abstract][Full Text] [Related]
16. Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.
Sali M; Di Sante G; Cascioferro A; Zumbo A; Nicolò C; Donà V; Rocca S; Procoli A; Morandi M; Ria F; Palù G; Fadda G; Manganelli R; Delogu G
Infect Immun; 2010 Dec; 78(12):5202-13. PubMed ID: 20921146
[TBL] [Abstract][Full Text] [Related]
17. Co-immunization of plasmid DNA encoding IL-12 and IL-18 with Bacillus Calmette-Guérin vaccine against progressive tuberculosis.
Jeon BY; Eoh H; Ha SJ; Bang H; Kim SC; Sung YC; Cho SN
Yonsei Med J; 2011 Nov; 52(6):1008-15. PubMed ID: 22028167
[TBL] [Abstract][Full Text] [Related]
18. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin.
Rao V; Dhar N; Tyagi AK
Scand J Immunol; 2003 Oct; 58(4):449-61. PubMed ID: 14507310
[TBL] [Abstract][Full Text] [Related]
19. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen.
Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M
PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261
[TBL] [Abstract][Full Text] [Related]
20. Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette-Guérin over-producing three putative protective antigen candidates.
Ohara N; Matsuoka M; Nomaguchi H; Naito M; Yamada T
Vaccine; 2001 Feb; 19(15-16):1906-10. PubMed ID: 11228360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
